Showing results (281-290 of 303) with videos related to

Sort By:
Pageof 31
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|April 10, 2024
Genotype-by-environment interactions and local adaptation shape selection in the US National Chip Processing TrialHusain I Agha, Jeffrey B Endelman, Jessica Chitwood-Brown, et al.
Journal of Arrhythmia|February 28, 2022
Age-dependency of EHRA improvement based on quality of life at diagnosis of atrial fibrillationLuc J H J Theunissen, Henricus-Paul Cremers, Dennis van Veghel, et al.
Basic Research in Cardiology|October 16, 2015
Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarctionG P J van Hout, W W van Solinge, C M Gijsberts, et al.
Health and Quality of Life Outcomes|April 4, 2023
The prognostic value of quality of life in atrial fibrillation on patient valueLuc J H J Theunissen, Jeroen A A van de Pol, Gijs J van Steenbergen, et al.
Nature|July 10, 2025
Extreme river flood exposes latent erosion riskH J Barneveld, R M Frings, E Mosselman, et al.
Elife|October 19, 2013
A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosisVirginie Olive, Erich Sabio, Margaux J Bennett, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility studyNiels J Harlaar, Marjory Koller, Steven J de Jongh, et al.
Journal of Virological Methods|March 6, 2013
September through October 2010 multi-centre study in the Netherlands examining laboratory ability to detect enterovirus 68, an emerging respiratory pathogenGiovanna Jaramillo-Gutierrez, Kimberley S M Benschop, Eric C J Claas, et al.
Lancet (London, England)|July 17, 2007
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trialMiriam Koopman, Ninja F Antonini, Joep Douma, et al.
Investigational New Drugs|December 9, 2015
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II studyDidier Meulendijks, Laurens V Beerepoot, Henk Boot, et al.
Pageof 31